pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
590
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
belapectin
Liver Cirrhosis
Galectin-3
$GALT
GALECTIN THERAPEUTICS INC
0
catalysts
Phase 3
belimumab
Benlysta (belimumab)
Systemic Sclerosis (Scleroderma)
Tumor necrosis factor ligand superfamily member 13B
$GSK
GSK plc
0
catalysts
Phase 3
belzupacap sarotalocan
Uveal Melanoma
← prev
page 8 of 20
next →
131
Pain
89
Neurology
1
$AURA
Aura Biosciences, Inc.
0
catalysts
Phase 3
bemdaneprocel
Parkinson's Disease
BlueRock Therapeutics LP
0
catalysts
Phase 3
bexicaserin
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Longboard Pharmaceuticals Inc
0
catalysts
Phase 3
bezisterim
Alzheimer's Disease
$BIVI
BIOVIE INC.
0
catalysts
Phase 3
bifikafusp alfa + onfekafusp alfa
Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
Metastatic Melanoma
Philogen SpA
0
catalysts
Phase 3
bimatoprost CR
bimatoprost
Ocular Hypertension
Prostaglandin F2-alpha receptor
$SGP
SpyGlass Pharma, Inc.
0
catalysts
Phase 3
bimatoprost grenod
Ocular Hypertension
Kowa Co Ltd
0
catalysts
Phase 3
blarcamesine hydrochloride
Fragile X Syndrome
$AVXL
ANAVEX LIFE SCIENCES CORP.
0
catalysts
Phase 3
bomedemstat tosylate
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$MRK
Merck & Co., Inc.
0
catalysts
Phase 3
botaretigene sparoparvovec
Retinitis Pigmentosa (Retinitis)
Johnson & Johnson Innovative Medicine
0
catalysts
Phase 3
brelovitug
brelovitug [INN]
Hepatitis D
$MIRM
Mirum Pharmaceuticals, Inc.
0
catalysts
Phase 3
brilaroxazine hydrochloride
Schizophrenia
$RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
0
catalysts
Phase 3
brolucizumab
Beovu (brolucizumab)
Proliferative Diabetic Retinopathy (PDR)
Vascular endothelial growth factor A, long form
$NVS
NOVARTIS AG
0
catalysts
Phase 3
bucindolol hydrochloride
Gencaro (bucindolol hydrochloride)
Atrial Fibrillation
Adrenergic receptor alpha-1
Beta-1 adrenergic receptor
Genvara Biopharma Inc
0
catalysts
Phase 3
buntanetap tartrate
Parkinson's Disease
$ANVS
Annovis Bio, Inc.
0
catalysts
Phase 3
cadisegliatin
Type 1 Diabetes (Juvenile Diabetes)
$VTVT
vTv Therapeutics Inc.
0
catalysts
Phase 3
caficrestat
Cardiomyopathy
Aldo-keto reductase family 1 member B1
Biossil Inc
0
catalysts
Phase 3
camlipixant
Chronic Cough
P2X purinoceptor 3
$GSK
GSK plc
0
catalysts
Phase 3
cannabidiol 1
CardiolRx (cannabidiol)
Pericarditis
Cannabinoid receptor 1
$CRDL
Cardiol Therapeutics Inc.
0
catalysts
Phase 3
carenoprazan hydrochloride
Duodenal Ulcer
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Phase 3
carisbamate
Lennox-Gastaut Syndrome
SK Life Science Inc
0
catalysts
Phase 3
catequentinib hydrochloride
Soft Tissue Sarcoma
Advenchen Laboratories LLC
0
catalysts
Phase 3
cebranopadol
Pain
Nociceptin receptor
Opioid receptors; mu/kappa/delta
Tris Pharma Inc
0
catalysts
Phase 3
cediranib maleate
Epithelial Ovarian Cancer
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 3
celiprolol
EDSIVO (celiprolol [INN])
Ehlers-Danlos Syndrome Vascular Type (Type IV)
$ZVRA
ZEVRA THERAPEUTICS, INC.
0
catalysts
Phase 3
cemdisiran + pozelimab
Myasthenia Gravis
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 3
cenerimod
Systemic Lupus Erythematosus
Sphingosine 1-phosphate receptor 1
Idorsia Pharmaceutical Ltd
0
catalysts
Phase 3
cetoquagene parvec
Xerostomia
$MGTX
MeiraGTx Holdings plc
0
catalysts
